Loading…
Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model
Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepar...
Saved in:
Published in: | Vaccine 2008-12, Vol.26 (51), p.6555-6563 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3 |
container_end_page | 6563 |
container_issue | 51 |
container_start_page | 6555 |
container_title | Vaccine |
container_volume | 26 |
creator | Hagenaars, Niels Mastrobattista, Enrico Glansbeek, Harrie Heldens, Jacco van den Bosch, Han Schijns, Virgil Betbeder, Didier Vromans, Herman Jiskoot, Wim |
description | Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations. |
doi_str_mv | 10.1016/j.vaccine.2008.09.057 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66705555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X08013133</els_id><sourcerecordid>3500056621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEokvhEUCWEJzI4sRx4nAAoapQpEocAImbNbUnu14ce2s7K21flNfBYVet1EtzsTX5_P9jz18ULyu6rGjVvt8sd6CUcbisKRVL2i8p7x4Vi0p0rKx5JR4XC1q3TdlU9PdJ8SzGDaWUs6p_WpxUQjRC8HZR_L1A0GXy5TqvRPlxC8FE74gfyOCnQJx3oDfTDlxCTYwDlcwO5r1Ca4mabJoClhqD2f0HBjuhuwFybC9-IOfDgCrNirO-jyYZ796RuIVkwBIfVuDMDcxVAi5rjON0Wwh-SkjyJq3x8Mev0Bll0j6bESDjFLINUWuwFt0Kyeg12ufFkwFsxBfH9bT49eX859lFefn967ezz5el4h1LZSMarTUwzpu27mveYVvrtuO5PNSArO2ZEsBqCoIiwBXte2ANA952Q9XWyE6LtwfdbfDXE8YkRxPnlwGHfoqybTvK8_cgWPVt39GGZfD1PXCT5-DyJWR25CI309eZ4gdKBR9jwEFugxkh7GVF5RwQuZHHCcg5IJL2Mgckn3t1VJ-uRtR3p46JyMCbIwBRgR0COGXiLZfNm45Wc5ufDhzm190ZDDIqg06hNiFPW2pvHmzl4z0FZU2eLNg_uMd4d2sZa0nljznNc5ipyP65A_YPEJX1-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625832092</pqid></control><display><type>article</type><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><source>Elsevier</source><creator>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</creator><creatorcontrib>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</creatorcontrib><description>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2008.09.057</identifier><identifier>PMID: 18848856</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Administration, Intranasal ; Allergy and Immunology ; Animals ; Antibodies, Viral - blood ; Antigens ; Applied microbiology ; Biological and medical sciences ; Dose-Response Relationship, Immunologic ; Eggs ; Female ; Fundamental and applied biological sciences. Psychology ; Hemagglutination Inhibition Tests ; Immunity, Mucosal ; Immunization ; Immunization - methods ; Immunogenicity ; Immunoglobulin A, Secretory - analysis ; Immunoglobulin G - blood ; Infections ; Influenza ; Influenza A virus - immunology ; Influenza vaccination ; Influenza Vaccines - administration & dosage ; Influenza Vaccines - immunology ; Injections, Intramuscular ; Mice ; Mice, Inbred C57BL ; Microbiology ; Nasal vaccination ; Orthomyxoviridae Infections - prevention & control ; Pandemics ; Production capacity ; Proteins ; Split vaccine ; Subunit vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaccines, Inactivated - administration & dosage ; Vaccines, Inactivated - immunology ; Vaccines, Subunit - administration & dosage ; Vaccines, Subunit - immunology ; Virosomes ; Virosomes - administration & dosage ; Virosomes - immunology ; Whole inactivated virus</subject><ispartof>Vaccine, 2008-12, Vol.26 (51), p.6555-6563</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Dec 2, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</citedby><cites>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20947013$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18848856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hagenaars, Niels</creatorcontrib><creatorcontrib>Mastrobattista, Enrico</creatorcontrib><creatorcontrib>Glansbeek, Harrie</creatorcontrib><creatorcontrib>Heldens, Jacco</creatorcontrib><creatorcontrib>van den Bosch, Han</creatorcontrib><creatorcontrib>Schijns, Virgil</creatorcontrib><creatorcontrib>Betbeder, Didier</creatorcontrib><creatorcontrib>Vromans, Herman</creatorcontrib><creatorcontrib>Jiskoot, Wim</creatorcontrib><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</description><subject>Administration, Intranasal</subject><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Immunologic</subject><subject>Eggs</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Immunity, Mucosal</subject><subject>Immunization</subject><subject>Immunization - methods</subject><subject>Immunogenicity</subject><subject>Immunoglobulin A, Secretory - analysis</subject><subject>Immunoglobulin G - blood</subject><subject>Infections</subject><subject>Influenza</subject><subject>Influenza A virus - immunology</subject><subject>Influenza vaccination</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza Vaccines - immunology</subject><subject>Injections, Intramuscular</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiology</subject><subject>Nasal vaccination</subject><subject>Orthomyxoviridae Infections - prevention & control</subject><subject>Pandemics</subject><subject>Production capacity</subject><subject>Proteins</subject><subject>Split vaccine</subject><subject>Subunit vaccine</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaccines, Inactivated - administration & dosage</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Vaccines, Subunit - administration & dosage</subject><subject>Vaccines, Subunit - immunology</subject><subject>Virosomes</subject><subject>Virosomes - administration & dosage</subject><subject>Virosomes - immunology</subject><subject>Whole inactivated virus</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFksFu1DAQhiMEokvhEUCWEJzI4sRx4nAAoapQpEocAImbNbUnu14ce2s7K21flNfBYVet1EtzsTX5_P9jz18ULyu6rGjVvt8sd6CUcbisKRVL2i8p7x4Vi0p0rKx5JR4XC1q3TdlU9PdJ8SzGDaWUs6p_WpxUQjRC8HZR_L1A0GXy5TqvRPlxC8FE74gfyOCnQJx3oDfTDlxCTYwDlcwO5r1Ca4mabJoClhqD2f0HBjuhuwFybC9-IOfDgCrNirO-jyYZ796RuIVkwBIfVuDMDcxVAi5rjON0Wwh-SkjyJq3x8Mev0Bll0j6bESDjFLINUWuwFt0Kyeg12ufFkwFsxBfH9bT49eX859lFefn967ezz5el4h1LZSMarTUwzpu27mveYVvrtuO5PNSArO2ZEsBqCoIiwBXte2ANA952Q9XWyE6LtwfdbfDXE8YkRxPnlwGHfoqybTvK8_cgWPVt39GGZfD1PXCT5-DyJWR25CI309eZ4gdKBR9jwEFugxkh7GVF5RwQuZHHCcg5IJL2Mgckn3t1VJ-uRtR3p46JyMCbIwBRgR0COGXiLZfNm45Wc5ufDhzm190ZDDIqg06hNiFPW2pvHmzl4z0FZU2eLNg_uMd4d2sZa0nljznNc5ipyP65A_YPEJX1-A</recordid><startdate>20081202</startdate><enddate>20081202</enddate><creator>Hagenaars, Niels</creator><creator>Mastrobattista, Enrico</creator><creator>Glansbeek, Harrie</creator><creator>Heldens, Jacco</creator><creator>van den Bosch, Han</creator><creator>Schijns, Virgil</creator><creator>Betbeder, Didier</creator><creator>Vromans, Herman</creator><creator>Jiskoot, Wim</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20081202</creationdate><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><author>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Intranasal</topic><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Immunologic</topic><topic>Eggs</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Immunity, Mucosal</topic><topic>Immunization</topic><topic>Immunization - methods</topic><topic>Immunogenicity</topic><topic>Immunoglobulin A, Secretory - analysis</topic><topic>Immunoglobulin G - blood</topic><topic>Infections</topic><topic>Influenza</topic><topic>Influenza A virus - immunology</topic><topic>Influenza vaccination</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza Vaccines - immunology</topic><topic>Injections, Intramuscular</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiology</topic><topic>Nasal vaccination</topic><topic>Orthomyxoviridae Infections - prevention & control</topic><topic>Pandemics</topic><topic>Production capacity</topic><topic>Proteins</topic><topic>Split vaccine</topic><topic>Subunit vaccine</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaccines, Inactivated - administration & dosage</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Vaccines, Subunit - administration & dosage</topic><topic>Vaccines, Subunit - immunology</topic><topic>Virosomes</topic><topic>Virosomes - administration & dosage</topic><topic>Virosomes - immunology</topic><topic>Whole inactivated virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hagenaars, Niels</creatorcontrib><creatorcontrib>Mastrobattista, Enrico</creatorcontrib><creatorcontrib>Glansbeek, Harrie</creatorcontrib><creatorcontrib>Heldens, Jacco</creatorcontrib><creatorcontrib>van den Bosch, Han</creatorcontrib><creatorcontrib>Schijns, Virgil</creatorcontrib><creatorcontrib>Betbeder, Didier</creatorcontrib><creatorcontrib>Vromans, Herman</creatorcontrib><creatorcontrib>Jiskoot, Wim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hagenaars, Niels</au><au>Mastrobattista, Enrico</au><au>Glansbeek, Harrie</au><au>Heldens, Jacco</au><au>van den Bosch, Han</au><au>Schijns, Virgil</au><au>Betbeder, Didier</au><au>Vromans, Herman</au><au>Jiskoot, Wim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2008-12-02</date><risdate>2008</risdate><volume>26</volume><issue>51</issue><spage>6555</spage><epage>6563</epage><pages>6555-6563</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>18848856</pmid><doi>10.1016/j.vaccine.2008.09.057</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2008-12, Vol.26 (51), p.6555-6563 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_66705555 |
source | Elsevier |
subjects | Administration, Intranasal Allergy and Immunology Animals Antibodies, Viral - blood Antigens Applied microbiology Biological and medical sciences Dose-Response Relationship, Immunologic Eggs Female Fundamental and applied biological sciences. Psychology Hemagglutination Inhibition Tests Immunity, Mucosal Immunization Immunization - methods Immunogenicity Immunoglobulin A, Secretory - analysis Immunoglobulin G - blood Infections Influenza Influenza A virus - immunology Influenza vaccination Influenza Vaccines - administration & dosage Influenza Vaccines - immunology Injections, Intramuscular Mice Mice, Inbred C57BL Microbiology Nasal vaccination Orthomyxoviridae Infections - prevention & control Pandemics Production capacity Proteins Split vaccine Subunit vaccine Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology Vaccines, Subunit - administration & dosage Vaccines, Subunit - immunology Virosomes Virosomes - administration & dosage Virosomes - immunology Whole inactivated virus |
title | Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A45%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Head-to-head%20comparison%20of%20four%20nonadjuvanted%20inactivated%20cell%20culture-derived%20influenza%20vaccines:%20Effect%20of%20composition,%20spatial%20organization%20and%20immunization%20route%20on%20the%20immunogenicity%20in%20a%20murine%20challenge%20model&rft.jtitle=Vaccine&rft.au=Hagenaars,%20Niels&rft.date=2008-12-02&rft.volume=26&rft.issue=51&rft.spage=6555&rft.epage=6563&rft.pages=6555-6563&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2008.09.057&rft_dat=%3Cproquest_cross%3E3500056621%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625832092&rft_id=info:pmid/18848856&rfr_iscdi=true |